1427P - Biopsychosocial factors underlying older patients treated for an incurable cancer in a two-tiered health care system in Brazil

Date 10 September 2017
Event ESMO 2017 Congress
Session Poster display session
Topics Cancer in Adolescents
Psychosocial Aspects of Cancer
Geriatric Oncology
Palliative and Supportive Care
Presenter Cristiane Bergerot
Citation Annals of Oncology (2017) 28 (suppl_5): v507-v510. 10.1093/annonc/mdx384
Authors C.D. Bergerot1, K.T. Ashing2, E. Philip3, P.G. Bergerot1, N. Dizman1, S.K. Pal1, W. Dale4
  • 1Department Of Medical Oncology & Experimental Therapeutics, City of Hope, 91010 - Duarte/US
  • 2Department Of Population Sciences, City of Hope, 91010 - Duarte/US
  • 3The Notre Dame Laboratory For Psycho-oncology Research, University of Notre Dame, Notre Dame/US
  • 4Department Of Supportive Care Medicine, City of Hope, 91010 - Duarte/US

Abstract

Background

Patients with advanced cancer experience symptoms that include pain, fatigue, and depression. We sought to describe prevalence and identify factors associated with biopsychosocial distress in older patients (65+) diagnosed with cancer stage IV.

Methods

Participants were recruited from two different types of health care facilities, public [PUB] and private [PRI] institutions, in Brazil. A cross-sectional analysis of common biopsychosocial symptoms (anxiety, depression, pain, and fatigue), and quality of life reported by older patients undergoing chemotherapy treatment was performed.

Results

Older patients (n = 167) were enrolled (Mean age=73; SD = 5.6); 59.3% from PUB. Majority were female (56.3%; 38.9% PUB), white (68.9%; 35.7% PRI, p

Conclusions

Older patients with late-stage cancer in Brazil suffer substantial unrecognized morbidity which impacts their distress and QOL. Biopsychosocial screening for older patients should be included in quality cancer care. Moreover, patients treated within PUB show worse outcomes than PRI counterparts, and they are at higher risk for multiple physical, psychological, and financial morbidity. Earlier initiation of biopsychosocial screening with appropriate supportive care may improve their QOL.

Clinical trial identification

Legal entity responsible for the study

Cristiane Decat Bergerot

Funding

None

Disclosure

All authors have declared no conflicts of interest.